GRIN2C and chronic kidney disease: When 0.1 μM PPDA, a well-characterized antagonist of GluN2C/D, was perfused into the same slices, the sensitivity to PPDA was much greater in cKD mice than in the control group (Fig. 6c and Supplementary Fig. 6d).